Last update 24 Jun 2024

Atorvastatin/Omega-3-Acid Ethyl Esters

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
KI-1106
Target
HMG-CoA reductase x Lipid x Triglyceride
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), Lipid modulators, Triglyceride modulators
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Dyslipidemias
Originator Organization
Kuhnil Pharma Co., Ltd.
Active Organization-
Inactive Organization
Kuhnil Pharma Co., Ltd.
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-

Structure

Molecular FormulaC46H70O4
InChIKeyDTMGIJFHGGCSLO-FIAQIACWSA-N
CAS Registry861006-80-6
View All Structures (2)

Related

1
Clinical Trials associated with Atorvastatin/Omega-3-Acid Ethyl Esters
NCT03482180 / CompletedPhase 3
A Multi-Center, Randomized, Double-Blind, Parallel Phase III Study to Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
100 Clinical Results associated with Atorvastatin/Omega-3-Acid Ethyl Esters
Login to view more data
100 Translational Medicine associated with Atorvastatin/Omega-3-Acid Ethyl Esters
Login to view more data
100 Patents (Medical) associated with Atorvastatin/Omega-3-Acid Ethyl Esters
Login to view more data
100 Deals associated with Atorvastatin/Omega-3-Acid Ethyl Esters
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DyslipidemiasPhase 3-
Kuhnil Pharma Co., Ltd.
04 May 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03482180 (Pubmed)
ManualManual
Phase 3
Hypertriglyceridemia
200
glcdagrtot(slcpapwhjm) = erofbyxfgu epifafxeak (kqngexpaku )
View more
Positive
01 Feb 2020
Atorvastatin+Placebo
glcdagrtot(slcpapwhjm) = pzvqajdfrn epifafxeak (kqngexpaku )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free